[Nevirapine: a new principle of action against HIV].
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000494:pharmacology*; D002648:Child; D002986:Clinical Trials as Topic; D016049:Didanosine / Q000008:administration & dosage; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005260:Female; D006678:HIV / Q000187:drug effects*; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D019829:Nevirapine; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy; D011725:Pyridines / Q000008:administration & dosage* / Q000494:pharmacology*; D016032:Randomized Controlled Trials as Topic; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage* / Q000494:pharmacology*; D013997:Time Factors; D015215:Zidovudine / Q000008:administration & dosage
D019380:Anti-HIV Agents; D011725:Pyridines; D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine; D019829:Nevirapine; D016049:Didanosine